Skip to search formSkip to main contentSkip to account menu

Linagliptin 5 MG Oral Tablet [Tradjenta]

Known as: Tradjenta 5 MG Oral Tablet, linagliptin 5 mg ORAL TABLET, FILM COATED [Tradjenta] 
National Institutes of Health

Related topics

Related topics

4 relations
LinagliptinOral TabletTradjenta

Broader (1)

Linagliptin Oral Tablet [Tradjenta]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Lingaliptin ( Tradjenta ® ) : A New DPP-4 Inhibitor for Type 2 Diabetes
STATIN THERAPY TO ACHIEVE CHOLESTEROL AND NON-CHOLESTEROL GOALS OF DECREASED MORBIDITY AND MORTALITY he Centers for Disease… 
Review
2011
Review
2011
Tradjenta™ (linagliptin) Tablets A New Type 2 Diabetes Treatment Option for Adult Patients with Inadequate Glycemic Control: Clinical Trials Review, Part 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)